Unknown

Dataset Information

0

Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.

ABSTRACT:

SUBMITTER: Yannuzzi NA 

PROVIDER: S-EPMC7119243 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.

Yannuzzi Nicolas A NA   Sridhar Jayanth J   Chang Jonathan S JS   Lin James J   Kuriyan Ajay E AE   Smiddy William E WE  

Ophthalmology 20180320 7

Similar Datasets

Unknown Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.
| S-EPMC6108778 | biostudies-literature
Unknown Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema.
| S-EPMC9226173 | biostudies-literature
Unknown Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
| S-EPMC8343518 | biostudies-literature
Unknown Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review.
| S-EPMC8655445 | biostudies-literature
Unknown Longitudinal Quantitative Ultrawidefield Angiographic Features in Diabetic Retinopathy Treated with Aflibercept from the Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement Trial.
| S-EPMC10872550 | biostudies-literature
Unknown Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study).
| S-EPMC7574886 | biostudies-literature
Unknown Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.
| S-EPMC5376507 | biostudies-literature
Unknown The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept.
| S-EPMC8619795 | biostudies-literature
Unknown Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
| S-EPMC7317653 | biostudies-literature
Unknown Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment.
| S-EPMC9726866 | biostudies-literature